Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study

BackgroundThe triglyceride glucose (TyG) index is an easily accessible surrogate marker of insulin resistance, an important pathway in the development of type 2 diabetes and cardiovascular diseases. However, the association of the TyG index with cardiovascular diseases and mortality has mainly been investigated in Asia, with few data available from other regions of the world. We assessed the association of insulin resistance (as determined by the TyG index) with mortality and cardiovascular diseases in individuals from five continents at different levels of economic development, living in urban or rural areas. We also examined whether the associations differed according to the country's economical…

• A
  AstraZeneca
• G
  GlaxoSmithKline
• S
  Sanofi
• HA
  Heart and Stroke Foundation of Canada
• DA
  Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS)
• AC
  AstraZeneca Canada
• NP
  Novartis Pharmaceuticals Corporation
• BI
  Boehringer Ingelheim
• HH
  Hamilton Health Sciences
• DF
  Dairy Farmers of Canada
• PH
  Public Health Agency of Canada
• RH
  Riksförbundet HjärtLung
• OM
  Ontario Ministry of Health and Long-Term Care
• SA
  South African Medical Research Council
• IC
  Indian Council of Medical Research
• SH
  Saudi Heart Association
• MO
  Ministry of Higher Education, Malaysia
• KS
  Kementerian Sains, Teknologi dan Inovasi
• V
  Vetenskapsrådet
• ME
  Ministerstwo Edukacji i Nauki
• S
  Servier
• UN
  United Nations Relief and Works Agency for Palestine Refugees
• CI
  Canadian Institutes of Health Research
• PC
  Philippine Council for Health Research and Development
• FH
  Fuwai Hospital, Chinese Academy of Medical Sciences